# The Brain’s Redox Crisis: NAD, Mitochondria, and the Next Wave of Neuropsychiatric Treatment

Page: https://stenobird.com/podcast/the-energy-code-2136601/the-brain-s-redox-crisis-nad-mitochondria-and-the-next-wave-of-neuropsychiatric-treatment
Text version: https://stenobird.com/podcast/the-energy-code-2136601/the-brain-s-redox-crisis-nad-mitochondria-and-the-next-wave-of-neuropsychiatric-treatment.md
Podcast: [The Energy Code](https://stenobird.com/podcast/the-energy-code-2136601)
Published: 2026-04-24T15:26:03+00:00
Episode link: https://theenergycode.podbean.com/e/the-brain-s-redox-crisis-nad-mitochondria-and-the-next-wave-of-neuropsychiatric-treatment/
Audio file: https://mcdn.podbean.com/mf/web/fewvmznt4upi7iwj/redox_mixdown.mp3
Processing state: processed
JSON: https://stenobird.com/v1/public/podcasts/the-energy-code-2136601/episodes/the-brain-s-redox-crisis-nad-mitochondria-and-the-next-wave-of-neuropsychiatric-treatment
Duration seconds: 1128

## Resource

Neuropsychiatric and neurodegenerative diseases may share a common underlying pathology: a breakdown in the brain's redox balance. This deep dive explores how disruptions in the NAD+/NADH ratio drive mitochondrial failure and inflammation across diverse diagnoses.

## Highlights
- Main idea: Redox dysregulation, specifically the NAD+/NADH ratio, acts as a shared organizing principle for both neurodegeneration and psychiatric illness
- Failure mode: Raising NAD levels in the blood does not guarantee the correction of compartmentalized redox failure within specific brain cells
- Practical takeaway: Ketogenic therapy may offer benefits beyond alternative fuel by actively modulating the NAD+/NADH redox state
- Critical bottleneck: The field lacks robust in vivo biomarkers to prove that redox-based therapies are actually engaging their targets in the brain
- Future direction: Effective treatment must shift from broad supplementation to mechanism-driven, precision interventions based on metabolic signatures

## Topics

Neuropsychiatry, Mitochondrial Dysfunction, NAD+, Redox Signaling, Alzheimer's Disease, Schizophrenia, Ketogenic Therapy, Bioenergetics, Biomarker Development

## Chapters
- 1:00 — Redox Failure as a Shared Pathology: An introduction to the thesis that brain disorders are fundamentally issues of redox and bioenergetic failure.
- 2:00 — The NAD+/NADH Ratio: Defining redox balance through the lens of metabolic control and mitochondrial efficiency.
- 4:00 — Beyond Protein Aggregation: Why targeting amyloid and tau has failed and why we must look toward mitochondrial stress.
- 5:00 — Psychiatric Implications: How schizophrenia and bipolar disorder exhibit similar energetic vulnerabilities to neurodegenerative diseases.
- 6:00 — Targeting NAD+: The potential and the specific molecular importance of NAD in restoring cellular function.
- 8:00 — The Compartmentalization Problem: The challenge of ensuring therapies reach the cytosol, mitochondria, and nucleus effectively.
- 9:00 — The Need for Biomarkers: Why measurement and target engagement are more critical to the field than new supplements.
- 10:00 — Ketogenic Redox Modulation: How ketogenic interventions influence the redox state and improve metabolic flexibility.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-energy-code-2136601/episodes/the-brain-s-redox-crisis-nad-mitochondria-and-the-next-wave-of-neuropsychiatric-treatment/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-energy-code-2136601/the-brain-s-redox-crisis-nad-mitochondria-and-the-next-wave-of-neuropsychiatric-treatment.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.